Cerebrospinal fluid methylome-based liquid biopsies for accurate malignant brain neoplasm classification
Neuro-Oncology · 03.08.2023 · 25 (8) · 1452-1460
DOI: 10.1093/neuonc/noac264 ↗Kurz gefasst
Fachartikel in der Zeitschrift Neuro-Oncology, online erschienen am 01.12.2022. Verfasst von Jeffrey A Zuccato und 14 weiteren Autor:innen. Beteiligte Einrichtung: MacFeeters Hamilton Neuro-Oncology Program, Princess Margaret Cancer Centre, University Health Network and University of Toronto, Toronto, Ontario, C…. Hauptthemen laut MEDLINE: Brain Neoplasms, Central Nervous System Neoplasms, Glioblastoma. Die Arbeit wurde bisher 65-mal zitiert (Crossref) und nennt 17 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, MacFeeters-Hamilton Grant.
Abstract (Originalsprache)
Background
Resolving the differential diagnosis between brain metastases (BM), glioblastomas (GBM), and central nervous system lymphomas (CNSL) is an important dilemma for the clinical management of the main three intra-axial brain tumor types. Currently, treatment decisions require invasive diagnostic surgical biopsies that carry risks and morbidity. This study aimed to utilize methylomes from cerebrospinal fluid (CSF), a biofluid proximal to brain tumors, for reliable non-invasive classification that addresses limitations associated with low target abundance in existing approaches.
Methods
Binomial GLMnet classifiers of tumor type were built, in fifty iterations of 80% discovery sets, using CSF methylomes obtained from 57 BM, GBM, CNSL, and non-neoplastic control patients. Publicly-available tissue methylation profiles (N = 197) on these entities and normal brain parenchyma were used for validation and model optimization.
Results
Models reliably distinguished between BM (area under receiver operating characteristic curve [AUROC] = 0.93, 95% confidence interval [CI]: 0.71–1.0), GBM (AUROC = 0.83, 95% CI: 0.63–1.0), and CNSL (AUROC = 0.91, 95% CI: 0.66–1.0) in independent 20% validation sets. For validation, CSF-based methylome signatures reliably distinguished between tumor types within external tissue samples and tumors from non-neoplastic controls in CSF and tissue. CSF methylome signals were observed to align closely with tissue signatures for each entity. An additional set of optimized CSF-based models, built using tumor-specific features present in tissue data, showed enhanced classification accuracy.
Conclusions
CSF methylomes are reliable for liquid biopsy-based classification of the major three malignant brain tumor types. We discuss how liquid biopsies may impact brain cancer management in the future by avoiding surgical risks, classifying unbiopsiable tumors, and guiding surgical planning when resection is indicated.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- MacFeeters Hamilton Neuro-Oncology Program, Princess Margaret Cancer Centre, University Health Network and University of Toronto, Toronto, Ontario, Canada.
- Division of Neurosurgery, Department of Surgery, University of Toronto, Toronto, Ontario, Canada.
- Terrence Donnelly Centre for Cellular and Biomolecular Research, University of Toronto, Toronto, Ontario, Canada.
- Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.
- Department of Neurosurgery, Penn State Milton S. Hershey Medical Center, Hershey, Pennsylvania, USA.
- Department of Medical Biophysics, University of Toronto, Toronto, Ontario, Canada.
ORCID-Profile: Jeffrey A Zuccato, Nicholas Mikolajewicz, Alireza Mansouri, Gelareh Zadeh
Förderung
- NCI NIH HHS
- MacFeeters-Hamilton Grant
Zitieren
APA
Zuccato, J. A., Patil, V., Mansouri, S., Voisin, M., Chakravarthy, A., Shen, S. Y., Nassiri, F., Mikolajewicz, N., Trifoi, M., Skakodub, A., Zacharia, B., Glantz, M., De Carvalho, D. D., Mansouri, A., & Zadeh, G. (2023). Cerebrospinal fluid methylome-based liquid biopsies for accurate malignant brain neoplasm classification. Neuro-Oncology, 25(8), 1452-1460. https://doi.org/10.1093/neuonc/noac264
Vancouver
Zuccato JA, Patil V, Mansouri S, Voisin M, Chakravarthy A, Shen SY, et al. Cerebrospinal fluid methylome-based liquid biopsies for accurate malignant brain neoplasm classification. Neuro-Oncology. 2023;25(8):1452-1460. doi:10.1093/neuonc/noac264
BibTeX
@article{Zuccato2023,
author = {Zuccato, Jeffrey A and Patil, Vikas and Mansouri, Sheila and Voisin, Mathew and Chakravarthy, Ankur and Shen, Shu Yi and Nassiri, Farshad and Mikolajewicz, Nicholas and Trifoi, Mara and Skakodub, Anna and Zacharia, Brad and Glantz, Michael and De Carvalho, Daniel D and Mansouri, Alireza and Zadeh, Gelareh},
title = {Cerebrospinal fluid methylome-based liquid biopsies for accurate malignant brain neoplasm classification},
journal = {Neuro-Oncology},
year = {2023},
volume = {25},
number = {8},
pages = {1452--1460},
doi = {10.1093/neuonc/noac264}
}
EUVIMED